Constellation Pharmaceuticals to Participate in Two Investor Conferences
21 Août 2019 - 3:00PM
Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a
clinical-stage biopharmaceutical company using its expertise in
epigenetics to discover and develop novel therapeutics, today
announced that the Company will participate in two investor
conferences on September 5. Jigar Raythatha, CEO, will meet
with investors at the Citi 14th Annual Biotech Conference at the
Four Seasons Hotel in Boston. Emma Reeve, CFO, will present
at the Baird Global Healthcare Conference at the InterContinental
Hotel in New York at 11:25 am EDT. A live audio webcast of
Ms. Reeve’s presentation and an archive for replay will be
available on the Investor Relations section of Constellation’s
website at
http://ir.constellationpharma.com/events-and-presentations/events.
The audio webcast replay will be available for 90 days following
the live presentation.
About Constellation Pharmaceuticals
Constellation Pharmaceuticals is a clinical-stage
biopharmaceutical company developing novel therapeutics that
selectively modulate gene expression to address serious unmet
medical needs in patients with cancer. The Company has a deep
understanding of how epigenetic and chromatin modifications in
cancer cells and in the tumor and immune microenvironment play a
fundamental role in driving disease progression and drug
resistance. Constellation is driving development of the EZH2
inhibitors CPI-1205 and CPI-0209 for the treatment of metastatic
castration-resistant prostate cancer and other cancers as well as
the BET inhibitor CPI-0610 for the treatment of
myelofibrosis. The Company is also applying its broad
research and development capabilities to explore other novel
targets that directly and indirectly impact gene expression to fuel
a sustainable pipeline of innovative small-molecule product
candidates.
ContactRonald Aldridge Investor
RelationsConstellation Pharmaceuticals+1
617-714-0539ron.aldridge@constellationpharma.com
Lauren ArnoldMedia RelationsMacDougall Biomedical
Communications+1 781-235-3060larnold@macbiocom.com
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur